Announcement of China Resources Shuanghe on the approval notice for sildenafil citrate tablets from its wholly-owned subsidiary China Resources Secco Pharmaceutical Co., Ltd.

SZSI · Oct 15

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.